je.st
news
Tag: drug
Vertex cystic fibrosis drug approved for another 500 U.S. patients
2014-12-29 22:34:29| Biotech - Topix.net
The U.S. Food and Drug Administration has approved Kalydeco by Vertex Pharmaceuticals for use in about 500 more cystic fibrosis patients than previously. Kalydeco is the Boston pharmaceutical company's only approved drug, following it's decision last year to discontinue its hepatitis C drug due to competition.
Tags: us
approved
drug
patients
Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I
2014-12-29 01:43:03| drugdiscoveryonline Home Page
PTC Therapeutics, Inc. (Nasdaq: PTCT) today announced that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted orphan-drug designation (ODD) to Translarna™ (ataluren) for the treatment of patients with Mucopolysaccharidosis I (MPS I)
Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
2014-12-29 01:32:30| drugdiscoveryonline Home Page
Microchips Biotech, Inc., formerly MicroCHIPS, Inc., recently announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years
Tags: and
development
delivery
efforts
X-Chem Licenses Cardiovascular Drug Discovery Program To Bayer Pharma AG
2014-12-29 01:28:39| drugdiscoveryonline Home Page
X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, recently announced it has licensed a second drug discovery program to Bayer Pharma AG pursuant to the multi-target collaboration the companies established in July 2012
Tags: program
drug
discovery
licenses
Enamine Announces Extension Of Collaboration With Sanofi In Early Drug Discovery
2014-12-29 01:26:01| drugdiscoveryonline Home Page
Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, has announced that it has extended its collaboration agreement with Sanofi, an integrated global healthcare leader
Tags: early
drug
extension
collaboration
Sites : [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] next »